Who
Christopher Simon
Director
Company insider
Files Form 4 as: Director, Sotera Health; President & CEO, Haemonetics.
In numbers
- Trades disclosed
- 78
- Buys
- 1
- Sells
- 21
- Bought
- $2.1M
- Sold
- $22.2M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 29 Jun 2016
- Last trade
- 22 May 2026
- Last filed
- 27 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 May 2026filed 27 May 2026 | SHC Sotera HealthProviders & Facilities | SEC FORM 4 Code A | —14,970 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | SHC Sotera HealthProviders & Facilities | SEC FORM 4 Code A | —14,970 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code F | $545K9,681 at $56.29 | filing |
| 15 May 2026filed 19 May 2026 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code A | —78,344 | filing |
| 15 May 2026filed 19 May 2026 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code F | $545K9,681 at $56.29 | filing |
| 15 May 2026filed 19 May 2026 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code A | —78,344 | filing |
| 30 May 2025filed 3 Jun 2025 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code A | —66,666 at $0.00 | filing |
| 30 May 2025filed 3 Jun 2025 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code F | $1.8M26,234 at $69.38 | filing |
| 22 May 2025filed 27 May 2025 | SHC Sotera HealthProviders & Facilities | SEC FORM 4 Code A | —19,132 at $0.00 | filing |
| 16 May 2025filed 20 May 2025 | HAE Haemoneticsoption or derivative · Medical Devices | SEC FORM 4 Code A | —46,342 at $0.00 | filing |
| 16 May 2025filed 20 May 2025 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code A | —21,405 | filing |
| 16 May 2025filed 19 May 2025 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code F | $498K7,089 at $70.31 | filing |
| 15 May 2025filed 19 May 2025 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code F | $166K2,391 at $69.38 | filing |
| 29 Aug 2024filed 3 Sep 2024 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code J | $3.0M39,704 at $75.56 | filing |
| 6 Jun 2024filed 7 Jun 2024 | HAE Haemoneticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —104,516 at $0.00 | filing |
| 6 Jun 2024filed 7 Jun 2024 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code M | $4.4M104,516 at $41.64 | filing |
| 6 Jun 2024filed 7 Jun 2024 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code F | $6.2M71,335 at $87.38 | filing |
| 28 May 2024filed 29 May 2024 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code A | —106,062 at $0.00 | filing |
| 28 May 2024filed 29 May 2024 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code F | $4.0M41,736 at $95.73 | filing |
| 17 May 2024filed 21 May 2024 | HAE Haemoneticsoption or derivative · Medical Devices | SEC FORM 4 Code A | —32,140 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.